1. Congenital erythrocytosis. (9th May 2016) Authors: McMullin, M. F. Journal: International journal of laboratory hematology Issue: Volume 38:(2016) Supplement 1 Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1068: RISK-ADJUSTED SAFETY ANALYSIS OF PACRITINIB IN PATIENTS WITH MYELOFIBROSIS. (23rd June 2022) Authors: Vannucchi, A.; Pemmaraju, N.; Scott, B.; Savona, M.; Oh, S.; Palandri, F.; Al-Ali, H. K.; Sobas, M.; McMullin, M. F.; Gupta, V.; Yacoub, A.; Mesa, R.; Buckley, S.; Roman-Torres, K.; Verstovsek, S.; Harrison, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 958 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P579: A PHASE 4 STUDY OF FRACTIONATED GEMTUZUMAB OZOGAMICIN ON QT INTERVAL AND SAFETY IN PATIENTS WITH RELAPSED/REFRACTORY CD33-POSITIVE ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: Montesinos, P.; Kota, V.; Brandwein, J.; Bousset, P.; Benner, R. J.; Vandendries, E.; McMullin, M. F. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P989: DYNAMIC CHANGES IN THE HISTONE H3 LYSINE 27 TRIMETHYLATION EPIGENETIC LANDSCAPE FOLLOWING RUXOLITINIB ADMINISTRATION. (23rd June 2022) Authors: Greenfield, G.; McMullin, M. F.; Mills, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S197: NAVITOCLAX PLUS RUXOLITINIB IN JAK INHIBITOR-NAÏVE PATIENTS WITH MYELOFIBROSIS: PRELIMINARY SAFETY AND EFFICACY IN A MULTICENTER, OPEN-LABEL PHASE 2 STUDY. (23rd June 2022) Authors: Passamonti, F.; Foran, J.; Tandra, A.; De Stefano, V.; Laura Fox, M.; Mattour, A.; McMullin, M. F.; Perkins, A. C.; Rodriguez-Macías, G.; Sibai, H.; Qin, Q.; Potluri, J.; How, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The prevalence of CALR mutations in a cohort of patients with myeloproliferative neoplasms. (11th November 2015) Authors: Grinsztejn, E.; Percy, M. J.; McClenaghan, D.; Quintana, M.; Cuthbert, R. J. G.; McMullin, M. F. Journal: International journal of laboratory hematology Issue: Volume 38:Number 1(2016:Feb.) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗